6 Feb 2014 07:00

6 February 2014
Â
Â
IXICO plc
Appointment of Joint Broker
Â
IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, today announces the appointment of Daniel Stewart & Company as its joint broker with immediate effect.
Â
Â
Enquiries
Â
IXICO plc
+44 207 691 2064
Derek Hill, CEO
Charles Spicer, Director
Â
Peel Hunt LLP (Nominated Adviser and Joint Broker)
+44 207 418 8900
James Steel
Clare Terlouw
Â
Daniel Stewart & Company (Joint Broker)
+44 207 776 6550
Mark Treharne
David Hart
Â
FTI Consulting Limited (U.K. Investor and Media Relations)
+44 207 831 3113
John Dineen
Simon Conway
Â
About IXICO
IXICO, the brain health company, was founded in 2004 with a mission to translate image acquisition, management and analysis technology and know-how, which the founders had developed together, into commercial products targeting the expanding area of imaging to inform decision-making during drug development. This has resulted in commercially successful products being launched in the clinical trials (Phase 0-III) and experimental medicine markets and more recently launched into the wider clinical diagnostic market. Since incorporation, IXICO has been awarded contracts by eight of the top 15 global pharmaceutical companies as well as leading biotechnology companies. In October 2013, IXICO plc was admitted to trading on AIM. More information is available on www.ixico.com
Â
Â